@article{e290577600dd43f098863fce20b3c20b,
title = "Eligibility of Patients with Renal Impairment for Phase I Trials: Time for a Rethink?",
author = "\{Mejia Garcia\}, \{Alex V.\} and \{institutional affiliations\}, \{Additional authors and\}",
note = "Since the inception of Phase I clinical trials in cancer, patients with renal dysfunction have commonly been excluded from participation because of a poor outlook. Most cancer drugs are approved with limited information on the pharmacokinetics and/or pharmacodynamics of the drugs in patients with re ... Malik, L., Mejia, A., \& Weitman, S. (2014). Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?. European journal of cancer (Oxford, England : 1990), 50(17), 2893–2896. https://doi.org/10.1016/j.ejca.2014.09.001",
year = "2014",
language = "American English",
volume = "50",
journal = "European Journal of Cancer",
}